Applied Evidence

When the answer to vaccines is “No”

Author and Disclosure Information

 

From The Journal of Family Practice | 2018;67(6):348-351,359-364.

References

7. I heard that vaccines are made from aborted fetal tissue.

There are 5 vaccines (varicella, rubella, hepatitis A, shingles, and rabies vaccines) that were originally made using aborted fetal tissue. In 1960, tissue from 2 fetuses aborted by maternal choice (and not for the purpose of vaccine production) was used to propagate cell lines that are still used in vaccine development today.

Human cells provide advantages for vaccine production that other cells do not. Some viruses do not grow well in animal cells. Animal cells can introduce contamination by bacteria and viruses that are not carried in human cell lines. Vaccine production can be hindered or halted, resulting in a vaccine shortage, if animal products used in development are threatened (eg, if an illness strikes egg-producing chickens; eggs are used to make the influenza vaccine).22

Some patients, particularly those who are Catholic, may have concerns about these vaccines. The National Catholic Bioethics Center has prepared a statement regarding the use of these vaccines that may help settle any moral dilemmas.23 It reads:

“The cell lines under consideration were begun using cells taken from one or more fetuses aborted almost 40 years ago. Since that time, the cell lines have grown independently. It is important to note that descendent cells are not the cells of the aborted child.”

“One is morally free to use the vaccine regardless of its historical association with abortion. The reason is that the risk to public health, if one chooses not to vaccinate, outweighs the legitimate concern about the origins of the vaccine. This is especially important for parents, who have a moral obligation to protect the life and health of their children and those around them.”

Continue to: 8. Vaccines aren't studied—or monitored—thoroughly enough.

Pages

Recommended Reading

Which Herpes Zoster Vaccine is Most Cost-Effective?
Journal of Clinical Outcomes Management
Inflammatory markers predict vaccine response in HCV, HIV
Journal of Clinical Outcomes Management
ACIP vaccine update
Journal of Clinical Outcomes Management
Children with autism, younger siblings are undervaccinated
Journal of Clinical Outcomes Management
Waning vaccine immunity linked to pertussis resurgence
Journal of Clinical Outcomes Management
Measles exacts high toll among Europe’s youngest citizens
Journal of Clinical Outcomes Management
International travel updates
Journal of Clinical Outcomes Management
NIH launches early Ebola treatment trial
Journal of Clinical Outcomes Management
Simple tool improves inpatient influenza vaccination rates
Journal of Clinical Outcomes Management
Jump start immunizations in NICU
Journal of Clinical Outcomes Management